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Abstract: The intramolecular coupling of two C(sp3)@H bonds
to forge a C(sp3)@C(sp3) bond is enabled by 1,4-Pd shift from
a trisubstituted aryl bromide. Contrary to most C(sp3)@C(sp3)
cross-dehydrogenative couplings, this reaction operates under
redox-neutral conditions, with the C@Br bond acting as an
internal oxidant. Furthermore, it allows the coupling between
two moderately acidic primary or secondary C@H bonds,
which are adjacent to an oxygen or nitrogen atom on one side,
and benzylic or adjacent to a carbonyl group on the other side.
A variety of valuable fused heterocycles were obtained from
easily accessible ortho-bromophenol and aniline precursors.
The second C@H bond cleavage was successfully replaced with
carbonyl insertion to generate other types of C(sp3)-C(sp3)
bonds.
Transition-metal-catalyzed C@C bond formation by double
C@H bond cleavage, often termed cross-dehydrogenative
coupling (CDC) has emerged as a promising transformation
in organic synthesis.[1] However, in contrast to C(sp2)@C(sp2)
and C(sp2)@C(sp3) bond formation, the construction of C-
(sp3)@C(sp3) bonds through CDC is still very limited (Sche-
me 1a). So far, most of the existing methods involve oxidative
conditions and outer-sphere mechanisms which require two
weak C@H bonds, with a low bond dissociation energy or high
acidity. 1,n-Palladium shift, pioneered by Heck,[2] represents
a redox-neutral alternative to construct C@C bonds by double
C@H activation, thanks to an initial oxidative addition of a C@
X bond to a Pd0 catalyst.[3,4] Recently, we have exploited this
concept to generate remote C(sp2)@C(sp3) bonds by 1,4-Pd
shift into a C(sp2) position and C(sp3)@H activation.[5, 6]
However, using palladium shift to form C(sp3)@C(sp3) bonds
is arguably more challenging, due to the propensity of s-
alkylpalladium species to undergo protodemetallation or b-
hydride elimination, especially at high temperatures. Yet,
early work from Dyker showed that alkylpalladium inter-
mediates, generated from C(sp3)@H activation at methoxy
groups, are competent to perform subsequent C(sp2)@H or
C(sp3)@H activation.[7] In particular, when iodoarene 1 was
reacted with catalytic Pd(OAc)2 and stoichiometric carbonate
in DMF, the dimeric products 2a and 2b were isolated
(Scheme 1b).[7d] Mechanistically, a first C@I oxidative addi-
tion to an in situ-generated Pd0 complex triggers C(sp3)@H
activation at the ortho methoxy group to give a 5-membered
palladacycle, that undergoes oxidative addition of a second
molecule of substrate 1 to give the palladium(IV) intermedi-
ateA.[8] Reductive elimination from A forges the biaryl bond
and leads to the alkylpalladium(II) intermediate B. The latter
furnishes dibenzopyran 2a upon C(sp2)@H activation at the
ortho aryl group and reductive elimination, and dihydroben-
zofuran 2b upon C(sp3)@H activation at the ortho methyl
group and reductive elimination. We surmised that, if the
second oxidative addition leading to palladacycle A could be
avoided, substrates similar to 1 could give rise to simpler
dihydrobenzofurans through 1,4-Pd shift and C(sp3)@H/C-
(sp3)@H coupling.
In the past years, we and others showed that the
introduction of an appropriate ancillary ligand allows shutting
down this unproductive oxidative addition pathway and
generating a variety of ring systems by direct C(sp2)@C(sp3)
reductive elimination.[9] Moreover, it was shown that aryl
bromides 3 (Scheme 1c) tend to undergo 1,4-Pd shift through
carbonate or carboxylate-mediated proton transfer to gen-
erate alkylpalladium complex C.[10] Such alkylpalladium
intermediates can be trapped with boronic acids or amines
to give intermolecular C@C and C@N coupling products,[11] or
Scheme 1. 1,4-Pd shift for the formation of C(sp3)@C(sp3) bonds from
two C(sp3)@H bonds.
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undergo b-H elimination to give olefins.[10b,12] Alternatively,
we hypothesized that C might undergo a second C(sp3)@H
bond cleavage at an ortho alkyl group, similar to B, to provide
cyclic product 4 upon reductive elimination from the corre-
sponding palladacycle. This pathway, avoiding the undesired
self-condensation described in Scheme 1b, could be poten-
tially applicable to precursors containing diverse Y and Z
groups as well as C(sp3)@H bond types, to generate a variety
of fused heterocycles of interest for medicinal chemistry.
Herein, we report the development of this Pd shift-based
C(sp3)@C(sp3) bond forming method.
We first explored the reactivity of aryl bromide 5a in
standard Pd0/ligand-catalyzed C(sp3)@H activation conditions
(Scheme 2a). After a quick optimization,[13] we found that the
use of the well-defined Pd(PCy3)2 complex and stoichiometric
cesium pivalate as a mild stoichiometric base allowed
formation of 2,3-dihydrobenzofuran 7a in 92% yield. As
hypothesized, we did not observe the formation of dimers
analogous to 2a,b (Scheme 1b) under these conditions. The
reaction could be scaled up (78% yield on a tenfold scale) and
extended to other aryl bromides, easily accessible from
phenol precursors, to give dihydrobenzofurans 7b–e in mod-
erate to very good yields. The volatility of products 7b and 7c
was likely responsible for their moderate yields. Of note,
a carbaldehyde was well tolerated (7d), which is likely
enabled using the mildly basic cesium pivalate as the
stoichiometric base. Substitution was tolerated at the ortho
position to the second activated methyl group (7e), but not at
the ortho position to the bromine atom. Importantly, the
reaction also proceeded when an ester or amide group was
installed as R1 (7 f),[14] R2 (7g–j) or both R1 and R2 (7k), with
the latter being isolated as the trans diasteroisomer. Other R1
and R2 groups such as methyl led to a complete loss of
reactivity under these conditions, thus showing that the
current reaction is limited to primary and sufficiently acidic
secondary C(sp3)@H bonds. However, one should note that
the synthesized dihydrobenzofurans 7a–k are not accessible
through direct Pd0-catalyzed C(sp3)@H arylation from aryl
halides, which requires the presence of a quaternary center to
favor the intramolecular C@H activation step.[15] Moreover,
a double reaction was successfully conducted on a dibromo
substrate (5 l), easily derived from Bisphenol C through
electrophilic bromination and methylation, to furnish bis(di-
hydrobenzofuran) 7 l in good yield. In this remarkable
example, four C(sp3)@H bonds were activated and two
C(sp3)@C(sp3) bonds created.
Next, we considered the extension of the 1,4-Pd shift-
induced coupling to sp3 carbons adjacent to a nitrogen atom
(Scheme 2b). We were motivated by prior observations that
o-bromo-N-methylanilines tend to undergo demethylation
under Pd0/ligand-catalyzed conditions, presumably through
1,4-Pd shift and iminium formation.[16] Gratifyingly, this
undesired demethylation could be avoided upon deactivation
of the nitrogen atom with a trifluoroacetyl substituent
(substrate 6a), and after reoptimization of the reaction
conditions (cat. AdCO2H/stoich. Rb2CO3, 160 8C)
[13] indoline
8a was obtained in 74% yield. To the best of our knowledge,
this is the first example of 1,4-Pd shift adjacent to a nitrogen
atom leading to C@C bond formation. Substituents were well
tolerated on the arene ring (8b–e), but unlike dihydrobenzo-
furans the indoline was not formed when substituents were
introduced on the carbons undergoing C(sp3)@H bond
cleavage (R1, R2). Despite this limitation, this method is
also complementary to indoline synthesis through direct Pd0-
Scheme 2. Synthesis of 2,3-dihydrobenzofurans and indolines through C(sp3)@H/C(sp3)@H coupling. [a] Conditions A: Pd(PCy3)2 (10 mol%),
CsOPiv (1.0 equiv), toluene, 140 8C (sealed tube). [b] Performed on a tenfold scale. [c] Performed at 160 8C. [d] Performed using 20 mol% Pd. [e]
Conditions B: Pd(PCy3)2 (10 mol%), AdCO2H (30 mol%), Rb2CO3 (1.5 equiv), toluene, 160 8C (sealed tube). [f ] The amide hydrolysis product was
directly isolated.
catalyzed C(sp3)@H arylation.[17, 15b] As illustrated with the
structures of tasimelteon[18] and silodosin (Figure 1),[19] the
2,3-dihydrobenzofuran and indoline motifs are important
substructures found in many pharmaceuticals.
Next, we set out to extend this method to the construction
of 6-membered rings (Scheme 3a). Keeping in mind the
above reactivity limitation to primary and acidic secondary
C@H bonds, we found that aryl bromide 9a, containing an
acetyl instead of methyl group in ortho position to the
methoxy group which undergoes 1,4-Pd shift, furnished
chroman-4-one 10a in 72% yield, after further tuning the
reaction conditions (cat. AdCO2H/stoich. Cs2CO3, 120 8C).
[13]
The reaction was successfully extended to arylalkylketones
bearing substituents on the aromatic ring (10b–d), as well as
other alkyl groups (10e,f). Of note, such chroman-4-ones are
valuable heterocycles for drug discovery.[20]
In the absence of an enolizable position, the organo-
palladium intermediate arising from 1,4-Pd shift could
potentially attack the ketone to give a tertiary alcohol.[21]
Indeed, under more forcing conditions arylketones 11a–g
underwent 1,4-Pd shift/nucleophilic addition to give the
corresponding 2,3-dihydrobenzofuran-3-ols 12a–g in average
to good yields, thereby providing a conceptually simple
extension of the current method to a different type of C(sp3)@
C(sp3) bond formation (Scheme 3b). In principle, this reac-
tion requires a stoichiometric reductant to recycle Pd0 after
the carbonyl insertion step.[21] Given that cesium pivalate is
the only stoichiometric reagent in our case, we hypothesize
that the catalyst turnover is provided by anionic ligand
exchange with pivalate, giving rise to palladium(II) pivalate,
which regenerates Pd0 through homocoupling of toluene.[22]
The 2,3-dihydrobenzofuran-3-ol products were moderately
stable and underwent facile dehydration when left in CDCl3
at room temperature to give the corresponding benzofurans,
as illustrated with 13 f and 13g, hence providing a new entry
into this biologically important motif.[23]
Preliminary mechanistic investigations were conducted
with deuterated substrates. First, compound 9c-d3-1 was
submitted to the standard conditions forming chromanones
(Scheme 4). Surprisingly, no reaction occurred even after
prolonged heating, in contrast to its protiated isotopomer
9c.[24]At first glance, this result seems to translate a very large
kinetic isotope effect (KIE), typically observed in tunnel-
ing.[25] Further investigations on this singular behavior are
ongoing. In addition, equimolar mixtures of 9c and 9c-d3-2
led to the corresponding chromanone with a 50% deuterium
content on the a-carbonyl position at various conversions,
diagnostic of an absence of primary KIE at this position.[26]
These two experiments indicate that the first C(sp3)@H bond
cleavage is turnover-limiting, in agreement with the relative
acidities of the corresponding C@H bonds.
Figure 1. Bioactive molecules containing the 2,3-dihydrobenzofuran
and indoline motifs.
Scheme 3. Divergent behavior of o-methoxyphenylketones. [a] Condi-
tions C: Pd(PCy3)2 (10 mol%), AdCO2H (30 mol%), Cs2CO3
(1.0 equiv), toluene, 120 8C (sealed tube). [b] Conditions D: Pd(PCy3)2
(10 mol%), CsOPiv (3.0 equiv), toluene, 160 8C (sealed tube).
Scheme 4. Deuterium isotope effect.
In conclusion, we have successfully achieved the intra-
molecular coupling of two C(sp3)@H bonds to forge a C(sp3)@ 
C(sp3) bond using the 1,4-Pd shift strategy. A variety of 
valuable fused heterocycles were obtained from easily 
accessible ortho-bromo phenol and aniline precursors. This 
reaction is so far limited to moderately acidic C@H bonds, 
adjacent to an oxygen or nitrogen atom on one side and 
benzylic or adjacent to a carbonyl group on the other side, but 
extensions to less reactive C@H bonds are foreseen.
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